Global Oral Solid Dosage Contract Manufacturing Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Oral Solid Dosage Contract Manufacturing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Tablets
  • 1.2.3 Capsules
  • 1.2.4 Powders & Granules
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Oral Solid Dosage Contract Manufacturing Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Specialty/Midsize
  • 1.3.3 Generics
  • 1.3.4 Big Pharma
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Oral Solid Dosage Contract Manufacturing Market Perspective (2016-2027)
• 2.2 Oral Solid Dosage Contract Manufacturing Growth Trends by Regions
  • 2.2.1 Oral Solid Dosage Contract Manufacturing Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Oral Solid Dosage Contract Manufacturing Historic Market Share by Regions (2016-2021)
  • 2.2.3 Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Regions (2022-2027)
• 2.3 Oral Solid Dosage Contract Manufacturing Industry Dynamic
  • 2.3.1 Oral Solid Dosage Contract Manufacturing Market Trends
  • 2.3.2 Oral Solid Dosage Contract Manufacturing Market Drivers
  • 2.3.3 Oral Solid Dosage Contract Manufacturing Market Challenges
  • 2.3.4 Oral Solid Dosage Contract Manufacturing Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Oral Solid Dosage Contract Manufacturing Players by Revenue
  • 3.1.1 Global Top Oral Solid Dosage Contract Manufacturing Players by Revenue (2016-2021)
  • 3.1.2 Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Players (2016-2021)
• 3.2 Global Oral Solid Dosage Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Oral Solid Dosage Contract Manufacturing Revenue
• 3.4 Global Oral Solid Dosage Contract Manufacturing Market Concentration Ratio
  • 3.4.1 Global Oral Solid Dosage Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Contract Manufacturing Revenue in 2020
• 3.5 Oral Solid Dosage Contract Manufacturing Key Players Head office and Area Served
• 3.6 Key Players Oral Solid Dosage Contract Manufacturing Product Solution and Service
• 3.7 Date of Enter into Oral Solid Dosage Contract Manufacturing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Solid Dosage Contract Manufacturing Breakdown Data by Type

• 4.1 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Type (2016-2021)
• 4.2 Global Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Type (2022-2027)

5 Oral Solid Dosage Contract Manufacturing Breakdown Data by Application

• 5.1 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Application (2016-2021)
• 5.2 Global Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
• 6.2 North America Oral Solid Dosage Contract Manufacturing Market Size by Type
  • 6.2.1 North America Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
  • 6.2.2 North America Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
  • 6.2.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
• 6.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Application
  • 6.3.1 North America Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
  • 6.3.2 North America Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
  • 6.3.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
• 6.4 North America Oral Solid Dosage Contract Manufacturing Market Size by Country
  • 6.4.1 North America Oral Solid Dosage Contract Manufacturing Market Size by Country (2016-2021)
  • 6.4.2 North America Oral Solid Dosage Contract Manufacturing Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
• 7.2 Europe Oral Solid Dosage Contract Manufacturing Market Size by Type
  • 7.2.1 Europe Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
  • 7.2.2 Europe Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
  • 7.2.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
• 7.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Application
  • 7.3.1 Europe Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
  • 7.3.2 Europe Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
  • 7.3.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
• 7.4 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country
  • 7.4.1 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country (2016-2021)
  • 7.4.2 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
• 8.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Type
  • 8.2.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Application
  • 8.3.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region
  • 8.4.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
• 9.2 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Type
  • 9.2.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
  • 9.2.2 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
  • 9.2.3 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
• 9.3 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Application
  • 9.3.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
  • 9.3.2 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
  • 9.3.3 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
• 9.4 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country
  • 9.4.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country (2016-2021)
  • 9.4.2 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size (2016-2027)
• 10.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Type
  • 10.2.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Application
  • 10.3.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country
  • 10.4.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Catalent
  • 11.1.1 Catalent Company Details
  • 11.1.2 Catalent Business Overview
  • 11.1.3 Catalent Oral Solid Dosage Contract Manufacturing Introduction
  • 11.1.4 Catalent Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.1.5 Catalent Recent Development
• 11.2 DPx
  • 11.2.1 DPx Company Details
  • 11.2.2 DPx Business Overview
  • 11.2.3 DPx Oral Solid Dosage Contract Manufacturing Introduction
  • 11.2.4 DPx Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.2.5 DPx Recent Development
• 11.3 Lonza Group (Capsugel)
  • 11.3.1 Lonza Group (Capsugel) Company Details
  • 11.3.2 Lonza Group (Capsugel) Business Overview
  • 11.3.3 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Introduction
  • 11.3.4 Lonza Group (Capsugel) Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.3.5 Lonza Group (Capsugel) Recent Development
• 11.4 Piramal Pharma Solutions
  • 11.4.1 Piramal Pharma Solutions Company Details
  • 11.4.2 Piramal Pharma Solutions Business Overview
  • 11.4.3 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Introduction
  • 11.4.4 Piramal Pharma Solutions Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.4.5 Piramal Pharma Solutions Recent Development
• 11.5 Aenova
  • 11.5.1 Aenova Company Details
  • 11.5.2 Aenova Business Overview
  • 11.5.3 Aenova Oral Solid Dosage Contract Manufacturing Introduction
  • 11.5.4 Aenova Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.5.5 Aenova Recent Development
• 11.6 Jubilant
  • 11.6.1 Jubilant Company Details
  • 11.6.2 Jubilant Business Overview
  • 11.6.3 Jubilant Oral Solid Dosage Contract Manufacturing Introduction
  • 11.6.4 Jubilant Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.6.5 Jubilant Recent Development
• 11.7 Famar
  • 11.7.1 Famar Company Details
  • 11.7.2 Famar Business Overview
  • 11.7.3 Famar Oral Solid Dosage Contract Manufacturing Introduction
  • 11.7.4 Famar Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.7.5 Famar Recent Development
• 11.8 Boehringer Ingelheim
  • 11.8.1 Boehringer Ingelheim Company Details
  • 11.8.2 Boehringer Ingelheim Business Overview
  • 11.8.3 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Introduction
  • 11.8.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.8.5 Boehringer Ingelheim Recent Development
• 11.9 Fareva Holding
  • 11.9.1 Fareva Holding Company Details
  • 11.9.2 Fareva Holding Business Overview
  • 11.9.3 Fareva Holding Oral Solid Dosage Contract Manufacturing Introduction
  • 11.9.4 Fareva Holding Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.9.5 Fareva Holding Recent Development
• 11.10 AbbVie Contract Manufacturing
  • 11.10.1 AbbVie Contract Manufacturing Company Details
  • 11.10.2 AbbVie Contract Manufacturing Business Overview
  • 11.10.3 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Introduction
  • 11.10.4 AbbVie Contract Manufacturing Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.10.5 AbbVie Contract Manufacturing Recent Development
• 11.11 Nipro Pharma
  • 11.11.1 Nipro Pharma Company Details
  • 11.11.2 Nipro Pharma Business Overview
  • 11.11.3 Nipro Pharma Oral Solid Dosage Contract Manufacturing Introduction
  • 11.11.4 Nipro Pharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.11.5 Nipro Pharma Recent Development
• 11.12 Sopharma
  • 11.12.1 Sopharma Company Details
  • 11.12.2 Sopharma Business Overview
  • 11.12.3 Sopharma Oral Solid Dosage Contract Manufacturing Introduction
  • 11.12.4 Sopharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.12.5 Sopharma Recent Development
• 11.13 Mylan (DPT Laboratories)
  • 11.13.1 Mylan (DPT Laboratories) Company Details
  • 11.13.2 Mylan (DPT Laboratories) Business Overview
  • 11.13.3 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Introduction
  • 11.13.4 Mylan (DPT Laboratories) Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.13.5 Mylan (DPT Laboratories) Recent Development
• 11.14 Recipharm
  • 11.14.1 Recipharm Company Details
  • 11.14.2 Recipharm Business Overview
  • 11.14.3 Recipharm Oral Solid Dosage Contract Manufacturing Introduction
  • 11.14.4 Recipharm Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.14.5 Recipharm Recent Development
• 11.15 NextPharma
  • 11.15.1 NextPharma Company Details
  • 11.15.2 NextPharma Business Overview
  • 11.15.3 NextPharma Oral Solid Dosage Contract Manufacturing Introduction
  • 11.15.4 NextPharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.15.5 NextPharma Recent Development
• 11.16 Dishman
  • 11.16.1 Dishman Company Details
  • 11.16.2 Dishman Business Overview
  • 11.16.3 Dishman Oral Solid Dosage Contract Manufacturing Introduction
  • 11.16.4 Dishman Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.16.5 Dishman Recent Development
• 11.17 Aesica Pharmaceuticals
  • 11.17.1 Aesica Pharmaceuticals Company Details
  • 11.17.2 Aesica Pharmaceuticals Business Overview
  • 11.17.3 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Introduction
  • 11.17.4 Aesica Pharmaceuticals Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.17.5 Aesica Pharmaceuticals Recent Development
• 11.18 CordenPharma
  • 11.18.1 CordenPharma Company Details
  • 11.18.2 CordenPharma Business Overview
  • 11.18.3 CordenPharma Oral Solid Dosage Contract Manufacturing Introduction
  • 11.18.4 CordenPharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2016-2021)
  • 11.18.5 CordenPharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer